Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**discus intervertebralis + rhus toxicodendron** is a complex homeopathic preparation utilized primarily for the management of degenerative spinal disorders, intervertebral disc protrusion, and associated musculoskeletal pain. The formulation combines **Discus intervertebralis** (typically sourced from porcine tissue), which acts as an organotherapeutic component intended to support the structural integrity and metabolic homeostasis of the intervertebral discs, with **Rhus toxicodendron** (Toxicodendron pubescens), a botanical extract traditionally used in homeopathy to treat rheumatic pain and joint stiffness that improves with motion. This combination drug is designed to stimulate the body's endogenous regulatory mechanisms to address the underlying degradation of the spinal column while providing symptomatic relief for neuralgia and inflammation. It is commonly available in various forms, including oral globules and injectable ampoules for subcutaneous or intramuscular administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on discus intervertebralis + rhus toxicodendron.